More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Mouse OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine(r)
Mouse OPG (TNFRSF11B) PicoKine ELISA Kit standard curve
Mouse OPG (TNFRSF11B) PicoKine ELISA Kit standard curve
Mouse OPG (TNFRSF11B) PicoKine ELISA Kit standard curve

Mouse OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine(r)

Research Use Only
EK0481
Boster Bio
ReactivityMouse
DownloadDatasheet
DownloadMSDS
Product group Assays
Price on request
96 wells
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Boster Bio
  • Product Name
    Mouse OPG PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    93.7 pg/ml - 6,000 pg/ml
  • Assay Sensitivity
    <5 pg/ml
  • Assay Specificity
    Natural and recombinant mouse OPG
  • Assay Time
    20-25
  • Certification
    Research Use Only
  • Scientific Description
    Mouse OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Tnfrsf11b in cell culture supernatants, serum and plasma (EDTA). Sensitivity: 5pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity
    Mouse
  • Reactivity Supplier
    Mouse OPG
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity. Huang JM et al., 2021, Drug Des Devel Ther
    Read more
  • Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. Zhu M et al., 2020 Mar, Biomed Pharmacother
    Read more
  • Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss. Liu H et al., 2019 Jul, J Cell Physiol
    Read more
  • Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo. Cai C et al., 2018, Front Pharmacol
    Read more
  • (2R,3R)Dihydromyricetin inhibits osteoclastogenesis and bone loss through scavenging LPS-induced oxidative stress and NF-kappaB and MAPKs pathways activating. Zhang X et al., 2018 Nov, J Cell Biochem
    Read more